David A. Siegel Health Catalyst, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 170,500 shares of HCAT stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170,500
Previous 282,900
39.73%
Holding current value
$1.09 Million
Previous $2.62 Million
51.01%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding HCAT
# of Institutions
180Shares Held
47.6MCall Options Held
2.52MPut Options Held
10.8K-
Black Rock Inc. New York, NY5.36MShares$34.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.48MShares$28.6 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA2.63MShares$16.8 Million0.0% of portfolio
-
Daventry Group, LP New York, NY2.16MShares$13.8 Million6.51% of portfolio
-
Impax Asset Management Group PLC2.15MShares$13.8 Million0.07% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $350M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...